<DOC>
	<DOCNO>NCT00309062</DOCNO>
	<brief_summary>Safety efficacy recombinant birch pollen allergen treatment allergic rhinoconjunctivitis</brief_summary>
	<brief_title>Safety Efficacy Recombinant Birch Pollen Allergen Treatment Allergic Rhinoconjunctivitis</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis , Allergic , Seasonal</mesh_term>
	<criteria>Positive Skin Prick Test reaction birch pollen Positive RAST result birch pollen Positive Provocation Test result birch pollen Serious chronic diseases Other perennial allergy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>Allergy</keyword>
	<keyword>Birch pollen</keyword>
	<keyword>Recombinant</keyword>
</DOC>